Usher Institute of Population Health Sciences and Informatics

Lessons from major cardiovascular outcome trials

The seminar

The seminar will:

  • Underscore the importance of high-quality data from randomized controlled  clinical trials as the basis for evidence-based medicine.
  • Evaluate the pitfalls of surrogate measures as an estimate of the safety and efficacy of therapeutic modality.
  • Underscore how current practice standards and guidelines can and should be altered by robust clinical trial data.

Professor Marc Pfeffer

A noted researcher, Professor Pfeffer introduced, along with others, the concept that angiotensin-converting enzyme inhibitors (ACEIs) could attenuate adverse ventricular remodelling following myocardial infarction and that this use would result in a prolongation of survival and other clinical benefits.

Professor Pfeffer is considered as a team builder and takes pride in academic advancement of trainees and junior faculty collaborating on the trials. He was listed as one of the highly influential biomedical researchers of 1996-2011 in the European Journal of Clinical Investigation. 

Lunch and registration

Buffet lunch and registration from 12 noon.


Following the seminar, there will be a unique opportunity for PhD Students and early career researchers to join Professor Pfeffer in a workshop.


Craigmillar Room, NINE Bioquarter, Little France


Both events are free but booking is essential.

Please email clearly stating which event you wish to attend along with any dietary/mobility requirements.

Professor Marc Pfeffer
Jun 12 2017 -

Lessons from major cardiovascular outcome trials

Professor Marc Pfeffer, Dazu Professor of Medicine at Harvard Medical School. Senior Physician, Cardiovascular Division, Brigham and Women’s Hospital, Boston.

Craigmillar Room, NINE Bioquarter, Little France